曼恩斯特(301325) - 2024 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2024 reached ¥679,504,637.03, representing a 216.80% increase year-over-year[2] - The net profit attributable to shareholders was a loss of ¥7,846,877.86, a decline of 108.53% compared to the same period last year[2] - The net profit attributable to shareholders after deducting non-recurring gains and losses was a loss of ¥16,677,505.75, down 120.62% year-over-year[2] - Total operating revenue for Q3 2024 reached CNY 1,029,950,148.32, a significant increase of 83.5% compared to CNY 561,113,730.66 in the same period last year[21] - The net profit for Q3 2024 was CNY 50,620,203.07, a significant decrease from CNY 252,734,360.66 in the same period last year, representing a decline of approximately 80%[23] - The company reported a total comprehensive income of CNY 50,835,435.39 for Q3 2024, down from CNY 252,734,360.66 in the same quarter last year[25] Assets and Liabilities - The total assets at the end of the reporting period were ¥4,641,956,838.66, an increase of 24.34% from the end of the previous year[2] - The total assets of the company reached CNY 4,641,956,838.66, up from CNY 3,733,355,373.49, reflecting a growth of 24.3%[20] - The total liabilities increased to CNY 1,727,457,724.51 from CNY 743,537,656.80, a rise of 132.8%[20] - The company's equity attributable to shareholders decreased to CNY 2,932,539,845.41 from CNY 2,995,807,482.86, a decline of 2.1%[20] Cash Flow - The net cash flow from operating activities for the year-to-date was -¥441,579,016.63, a significant decline of 2,359.12%[2] - The net cash flow from operating activities was negative at CNY -441,579,016.63, contrasting with a positive cash flow of CNY 19,546,523.89 in the previous year[28] - The company experienced a significant increase in cash inflow from investment activities, totaling CNY 4,004,271,696.78 compared to CNY 1,122,721,307.05 in the previous year[28] - The cash outflow from financing activities was CNY 169,320,309.70, compared to CNY 60,973,621.31 in Q3 2023, indicating a substantial increase in financing costs[29] - Cash and cash equivalents at the end of the period totaled CNY 858,904,791.79, down from CNY 1,077,796,525.97 at the end of Q3 2023[29] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 14,497[8] - The top ten unrestricted shareholders hold a total of 20,000,000 shares, with the largest shareholder holding 4,134,794 shares, representing approximately 20.7% of the total[10] - The company reported a total of 93,741,245 restricted shares at the beginning of the period, with 22,176,178 shares released during the period, resulting in a total of 85,997,960 restricted shares at the end[15] - The company plans to release 9,316,316 shares from Shenzhen Xinyi Investment Development Co., Ltd. by May 12, 2026, which will increase its total unrestricted shares significantly[12] - The company has a total of 14,432,893 shares that are expected to be added to the unrestricted category in the upcoming months[15] - The company has identified several key shareholders involved in strategic placements, including Minsheng Securities and Qingdao Hanman Network Technology, which may influence future investment strategies[10] - The company is currently unaware of any relationships or agreements among other shareholders that could affect stock performance[11] - The company has a total of 1,340,831 shares from Hainan Henguan No. 5 Venture Capital Fund that will be released by May 13, 2024, indicating a potential increase in liquidity[14] - The company has a total of 2,812,500 shares held by Minsheng Securities, which may play a role in future financing activities[10] - The company has a total of 1,518,251 shares held by Ningbo Hemao Investment Center, which could impact market dynamics[10] - The company has a strategic focus on expanding its shareholder base and increasing the number of unrestricted shares available in the market[12] Operating Costs and Expenses - Total operating costs for Q3 2024 were CNY 970,523,986.78, up from CNY 278,539,387.67, reflecting a year-over-year increase of 248.5%[22] - Research and development expenses for Q3 2024 were CNY 74,570,578.63, compared to CNY 46,487,065.64, showing an increase of 60.5%[22] - The company reported a tax expense of CNY -3,665,361.10 for the quarter, a decrease from CNY 38,808,387.84 in the same period last year[23] - The company did not report any net profit from the merged entity under common control for the current and previous periods, indicating no contribution from this segment[24] Earnings Per Share - The company reported a basic earnings per share of -¥0.05 for the current period, a decrease of 107.81%[2] - Basic and diluted earnings per share were both CNY 0.45, a decrease from CNY 2.03 in Q3 2023[25]